Summary:
- This article discusses a new genetic therapy that has been shown to significantly reduce cholesterol levels in people with high cholesterol.
- The therapy works by targeting a gene called PCSK9, which plays a key role in regulating cholesterol levels in the body. By reducing the activity of this gene, the therapy can lower LDL (bad) cholesterol by up to 50%.
- This breakthrough could lead to a new and more effective treatment option for people with high cholesterol, which is a major risk factor for heart disease. The therapy is still in the early stages of development, but the results of this study are very promising.